| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
-Subunits in Rat Skeletal Muscle
Department of Clinical Physiology (A.V.C., J.W.R., H.W.-H., J.R.Z.), Karolinska Hospital, 171 76 Stockholm, Sweden; Department of Physiology and Pharmacology (A.V.C., J.W.R., E.F., H.W.-H., J.R.Z.), Karolinska Institute, 171 77 Stockholm, Sweden; Ludwig Institute for Cancer Research (M.V.K.), 751 24 Uppsala, Sweden; and Division de Néphrologie (E.F.), Hôpital Cantonal Universitaire, 1211 Genève 4, Switzerland
Address all correspondence and requests for reprints to: Alexander V. Chibalin, Ph.D., Department of Clinical Physiology, Karolinska Hospital M1:02, 171 76, Stockholm, Sweden.
| Abstract |
|---|
|
|
|---|
-subunits of
Na+,K+-adenosine triphosphatase in
response to insulin, high extracellular glucose concentration, and
phorbol 12-myristate 13-acetate was investigated in isolated rat soleus
muscle. All three stimuli increased
-subunit phosphorylation
approximately 3-fold. Phorbol 12-myristate 13-acetate- and high
glucose-induced phosphorylation of the
-subunit was completely
abolished by the PKC inhibitor GF109203X, whereas insulin-stimulated
phosphorylation was only partially reduced. Notably, insulin
stimulation resulted in phosphorylation of the
-subunit on serine,
threonine, and tyrosine residues, whereas high extracellular glucose or
phorbol 12-myristate 13-acetate stimulation mediated phosphorylation
only on serine and threonine residues. Insulin stimulation resulted in
translocation of Na+,K+-adenosine
triphosphatase
2-subunit to the plasma membrane and
increased Na+,K+-adenosine triphosphatase
activity in the same membrane fraction. High glucose had no effect on
-subunits distribution. Immunoprecipitation with antiphosphotyrosine
antibody and subsequent Western blot analysis with
anti-
1- and -
2-subunit antibodies
revealed that both
1- and
2-subunit
isoforms underwent phosphorylation on tyrosine residues in response to
insulin, although with different time course and magnitude. Thus, we
show that insulin-stimulated phosphorylation of
Na+,K+-adenosine triphosphatase
-subunit
occurs via a PKC- and tyrosine kinase-dependent mechanism, whereas
high glucose-induced phosphorylation is only PKC-dependent.
Phosphorylation of Na+,K+-adenosine
triphosphatase
-subunits may be involved in regulation of
Na+,K+-adenosine triphosphatase activity by
insulin or high extracellular glucose in skeletal muscle. | Introduction |
|---|
|
|
|---|
Short-term regulation of cellular Na+-pump
activity can be achieved by phosphorylation of its
-subunit
(2, 3, 4, 5). Numerous studies have documented that the
-subunit in
Na+,K+-ATPase preparations
purified from different species can be phosphorylated in
vitro on serine and threonine residues by PKC, PKA, and PKG
(6, 7, 8, 9). Activators of these protein kinases stimulate
endogenous Na+,K+-ATPase
-subunit phosphorylation in Xenopus oocyte homogenates
(6, 9) and in intact cells (10, 11). However,
the functional consequences of
Na+,K+-ATPase
-subunit
phosphorylation are tissue- and protein kinase-specific
(10, 11, 12, 13, 14, 15).
Skeletal muscle is one of the most important target tissues for
insulin, a hormone which plays a major role in the control of both
glucose transport and metabolism (16), as well as
K+ uptake, and thereby controlling the plasma
K+ concentration (17). This latter
effect of insulin is likely to be achieved through a stimulation of
Na+,K+-ATPase in skeletal
muscle and is not secondary to an increase in
[Na+]i via
Na+-H+ antiporter
stimulation (18). Insulin participates in regulation of
the sodium pump by phosphorylation. For instance, in kidney proximal
convoluted tubules, insulin stimulates
Na+,K+-ATPase activity in a
PKC-independent manner. This effect is abolished by tyrosine kinase
inhibition and mimicked by orthovanadate, a tyrosine phosphatase
inhibitor (19). The insulin-stimulated increase in
Na+,K+-ATPase activity has
been reported to be dependent on the
1-subunit
phosphorylation at Tyr-10 in rat kidney proximal tubule cells
(20). In contrast to the kidney proximal tubule (19, 21), the stimulation of Na-pump activity in muscle by insulin is
PKC-dependent (22) and is mediated, in part, by an
increase in cell surface appearance of
Na+,K+-ATPase in rat
skeletal muscle cells (23). After 30 min of in
vivo insulin exposure,
2- and
ß1-subunit abundance in the plasma membrane of
rat muscle has been shown to be increased, with no change in
1 or ß2 distribution
(24). Importantly, insulin-regulated glucose transporter
GLUT4 and
2-subunit of
Na+,K+-ATPase, despite many
similarities, do not share the same intramuscular location, suggesting
that the signaling pathway mediating the translocation process might be
different in each case (3). Recruitment of
Na+,K+-ATPase molecules to
the muscle plasma membrane has been observed in oxidative soleus and
red gastrocnemius but not glycolytic white gastrocnemius muscle
(24).
The major function of insulin is the control of whole-body glucose
homeostasis. Elevated blood glucose level is the diagnostic
characteristic of diabetes. Reduced
Na+,K+-ATPase activity in a
number of tissues has been reported in association with diabetes
(25). Furthermore, high extracellular glucose
concentrations have been shown to inhibit
Na+,K+-ATPase activity in
smooth muscle cells (26). Inhibition of
Na+,K+-ATPase in pancreatic
ß-cells, by high extracellular glucose, correlates with an increased
degree of phosphorylation of the
-subunit (27).
To date, the mechanisms of sodium pump activation and the role of
protein kinase-mediated phosphorylation of
Na+,K+- ATPase
subunits, in response to insulin, have not been defined. We
investigated whether insulin induces phosphorylation of the
Na+,K+-ATPase in rat
skeletal muscle and whether PKC and/or tyrosine kinases are involved in
this process. In addition, we determined whether
Na+,K+-ATPase
phosphorylation, in response to insulin, is
-subunit
isoform-specific.
| Materials and Methods |
|---|
|
|
|---|
-subunit
was performed using a polyclonal antibody, anti-NK1, raised against
purified rat kidney holoenzyme (10, 20). Specific
anti-
1-subunit monoclonal and
anti-
2-subunit polyclonal antibodies
(28) were generously provided by Dr. M. Caplan (Yale
University, New Haven, CT). Antiphosphotyrosine PY20 antibody
was from Transduction Laboratories, Inc. (Lexington, KY).
Human insulin (Actrapid) was from Novo Nordisk AS
(Copenhagen, Denmark). Phorbol 12-myristate 13-acetate (PMA), okadaic
acid, HNPA-(AH)3
(hydroxy-2-naphthalenylmethylphosphonic acid trisacetoxymethyl ester),
peroxyvanadate, and GF109203X were from Calbiochem (La
Jolla, CA). Dimethylsulfoxide from Calbiochem was used as
a solvent for protein kinases and phosphatase inhibitors and
activators. All other reagents were of analytical grade
(Sigma, St. Louis, MO).
Animals and muscle incubation
Male Wistar rats (120130 g) were purchased from B & K
Universal (Sollentuna, Sweden) and housed in the animal facility at the
Karolinska Hospital for 1 wk before use. The Animal Ethical Committee
of the Karolinska Institute approved all protocols. Animals were fasted
overnight before experiments. Rats were anesthetized with ip injection
of sodium pentobarbital (5 mg/100 g BW). Soleus muscles were removed
and split longitudinally. Media were prepared from pregassed (95%
O2-5% CO2) Krebs Henseleit
buffer (KHB) containing 5 mM HEPES and 0.1% BSA (RIA
grade). Soleus muscles were incubated (30 min) in a shaking water bath
(30 C) in 2 ml KHB, supplemented with 5 mM glucose and 15
mM mannitol. Muscles were transferred to fresh KHB and
incubated without or with 120 nM insulin or 5
µM PMA. When pharmacological inhibitors were used, an
additional 30-min incubation was introduced to preexpose the muscle to
the inhibitor. Once added, inhibitors remained present for the duration
of the experiment. The final concentration of dimethylsulfoxide was
adjusted to 0.1% for each group. Incubation was terminated by freezing
the muscle with tongs precooled in liquid nitrogen.
Incubation of rat soleus muscles with 32Pi
Muscles were incubated for 60 min at 30 C in oxygenated
low-phosphate KHB (0.3 mM Pi) supplemented with 5
mM glucose and 15 mM mannitol containing 5
mM HEPES and 0.1% BSA (RIA grade) to reduce the endogenous
Pi content in the muscle. Muscles were then incubated in identical
medium containing 32Pi (1 mCi/ml) for 2 h.
Protein kinase inhibitors, PMA, or insulin were added during the last
1040 min of incubation time, as described above. Incubation was
terminated by freezing muscles in liquid nitrogen. Muscles were
homogenized as described below in Immunoprecipitation. The
-subunit was immunoprecipitated, separated by SDS-PAGE, and
transferred to nitrocellulose membranes. In every experiment, the
amount of radioactivity incorporated into the
-subunit was corrected
for the amount of the protein detected by Western blot, and the
quantitative data are shown as percent of basal.
Immunoprecipitation
Soleus muscles were pulverized in liquid nitrogen and
homogenized in Eppendorf tubes with a Pellet Pestle Motor,
(Kebo Lab, Stockholm, Sweden) in 0.5 ml ice-cold lysis buffer
containing 20 mM Tris (pH 8.0), 135 mM NaCl, 1
mM MgCl2, 2.7 mM KCl, 10
mM
Na4P2O7,
10 mM NaF, 1 mM
Na3VO4, 1 µM
okadaic acid, 1% Triton X-100, 10% vol/vol glycerol, 0.2
mM phenylmethylsulfonyl fluoride, and 1 µg/ml each of
aprotinin, leupeptin, and pepstatin. Insoluble material was removed by
centrifugation (12,000 x g for 10 min at 4 C). Protein
was determined using a bicinchoninic acid protein assay kit
(Pierce Chemical Co., Rockford, IL). Aliquots of
supernatant (750 µg protein) were immunoprecipitated overnight at 4 C
with 50 µl of polyclonal anti-NK1 antibodies or antiphosphotyrosine
antibody PY20. Immunoprecipitates were collected on protein A-Sepharose
beads (Pharmacia Biotech, Uppsala, Sweden) and
washed four times in lysis buffer; twice in 0.1 M
Tris (pH 8.0) and 0.5 M LiCl; once in 10
mM Tris (pH 7.6), 0.15 M
NaCl, and 1 mM EDTA; and once in 20
mM HEPES, 5 mM
MgCl2, and 1 mM
dithiothreitol. Pellets were resuspended in Laemmli sample buffer.
Proteins were separated by SDS-PAGE and transferred to nitrocellulose
membranes and subjected to Western blot with appropriate antibodies.
Phosphoproteins were analyzed using a PhosphoImager (Bio-Rad Laboratories, Inc., Hercules, CA), and quantitation was
performed using the Molecular Imager software (Bio-Rad Laboratories, Inc.).
Phosphoamino acid analysis
The phosphorylated
-subunit was immunoprecipitated and
resolved by SDS-PAGE, and the 32P-labeled
Na+,K+-ATPase
-subunits
were identified on the membrane by PhosphoImager and cut out.
Thereafter, the phosphorylated
-subunit was hydrolyzed in 6
M HCl and analyzed by two-dimensional high-voltage
electrophoresis on cellulose thin-layer plates. Phosphoamino acid
analysis was performed essentially as described by Boyle et
al. (29). Phosphoamino acids, on thin-layer
electrophoresis plates, were analyzed using a PhosphoImager.
Subcellular fractionation of rat skeletal muscle membranes
Cell surface and intracellular membrane fractions were isolated
by differential centrifugations and discontinuous sucrose gradients as
previously described (23, 24). Rat soleus muscles were
incubated with 120 nM insulin for 10 min and with 25
mM glucose for 30 min as described above. Approximately 350
mg rat skeletal muscle was weighed, minced, and initially homogenized
with a Polytron at a low speed (setting 4, 2 x 10 sec) in
homogenization buffer (20 mM Tris-HCl, 0.25 M
sucrose, 1 mM EDTA, 1 µM okadaic acid, 1
mM phenylmethylsulfonyl fluoride, and 10 µg/ml each of
aprotinin, leupeptin, and pepstatin). The resulting homogenate was
centrifuged for 10 min at 3,000 x g. The supernatant
was collected and kept on ice. The pellet was resuspended in
homogenization buffer and centrifuged again for 10 min at 3,000 x
g. The two supernatants were pooled and centrifuged for 20
min at 12,000 x g. The supernatants were collected and
then pelleted for 1 h at 150,000 x g. The crude
membrane pellets were resuspended in 500 µl homogenization buffer and
layered on top of a discontinuous density gradient consisting of 1.5 ml
of 35%, 1.5 ml of 30%, and 1.5 ml of 25% sucrose. After
centrifugation for 16 h at 77,000 x g, three
protein fractions were collected: fraction 25 on top of the 25% layer;
fraction 30 from the interphase 2530%; fraction 35 from the
interphase 3035%. All the fractions were collected, diluted with 20
mM Tris-HCl (pH 7.4), and centrifuged for 60 min
at 150,000 x g. Pellets were resuspended in 20
mM Tris-HCl, 0.25 M
sucrose, pH 7.4. Protein concentrations were determined as described
above. Fraction 25 has been previously characterized as a cell surface
membrane fraction enriched with plasma membranes (23).
Determination of Na+,K+-ATPase activity
Na+,K+-ATPase
activity was measured at maximum velocity (Vmax)
conditions in homogenates and membrane fractions, essentially as
described (13, 14). Rat soleus muscles, frozen in liquid
nitrogen, were homogenized in buffer (final vol, 300 µl) containing
50 mM Tris-HCl (pH 7.6), 2 mM EGTA, 250
mM sucrose, 1 µM okadaic acid, and 1
µM peroxyvanadate in glass/glass homogenizer. Homogenates
were centrifuged at 12,000 x g for 10 min at 4 C, and
supernatants were collected. Aliquots of the supernatants (protein
content, 3040 µg) or isolated membrane fractions (protein content,
23 µg) were transferred to the
Na+,K+-ATPase assay medium
(final vol, 100 µl), containing 50 mM NaCl, 5
mM KCl, 10 mM
MgCl2, 1mM EGTA, 50
mM Tris-HCl, 10 mM
Na2ATP, and
-32P-ATP
(NEN Life Science Products; specific activity, 3000
Ci/mmol) in tracer amounts (3.3 nCi/µl), at 4 C. The samples were
then incubated at 37 C for 15 min. The reaction was terminated by rapid
cooling to 4 C and addition of a mixture of trichloroacetic
acid/charcoal (5%/10%). After separating the charcoal phase
(12,000 x g for 5 min) containing the nonhydrolyzed
nucleotide, the 32Pi liberated in the supernatant
was counted. Na+,K+-ATPase
activity was calculated as the difference between test samples (total
ATPase activity) and samples assayed in a medium devoid of
Na+ and K+ and in the
presence of 2 mM ouabain (ouabain-insensitive
ATPase activity). Protein determination was performed as described
above.
Statistics
Comparisons between two experimental groups were made by the
t test. For multiple comparisons, one-way ANOVA with
Sheffes correction was used. P < 0.05 was considered
significant.
| Results |
|---|
|
|
|---|
-subunits of
Na+,K+-ATPase from rat soleus muscle in
response to insulin
-subunit.
Insulin increased the
-subunit phosphorylation approximately 3-fold
after 10 min of incubation (Fig. 1
-subunit
was transient. Phosphorylation returned to basal levels after 30 min of
insulin stimulation (Fig. 1
-subunit was dephosphorylated by protein phosphatases. PMA, a
well-characterized PKC activator that potently induces
Na+,K+-ATPase
-subunit
phosphorylation in a number of tissues (6, 10, 15), was
used for comparison. PMA increased basal
-subunit phosphorylation
3-fold. This PMA-dependent increase in phosphorylation was
inhibited in the presence of 5 µM PKC inhibitor
GF109203X.
|
-subunit in the absence or presence of protein kinase inhibitors
-
subunit phosphorylation, we examined the effects of the PKC
inhibitor GF109203X and the insulin receptor tyrosine kinase inhibitor
HNMPA-(AM)3 (32) on
-subunit
phosphorylation in soleus muscle. Preincubation of muscle (30 min) with
HNMPA-(AM)3 completely abolished the effect of
insulin on Na+,K+-ATPase
-subunit phosphorylation (Fig. 2
-subunit.
HNMPA-(AM)3 had no effect on basal
phosphorylation of the
Na+,K+-ATPase
-subunit.
|
-subunit
in rat soleus muscle (Fig. 2
-subunit,
whereas a 5-µM concentration of inhibitor partially
decreased insulin-stimulated 32P-incorporation
into the
-subunit. This suggests that atypical PKCs participate in
insulin-induced phosphorylation of the
Na+,K+-ATPase
-subunit
(Fig. 2
Effect of high extracellular glucose on
Na+,K+-ATPase
-subunit phosphorylation
High extracellular glucose has been suggested to stimulate
Na+,K+-ATPase
-subunit
phosphorylation by PKC-dependent mechanism in pancreatic ß-cells
(27). High glucose concentrations induce PKCs
translocation from cytosol to the membrane in rat soleus muscle
(34). To assess whether high extracellular glucose induces
Na-pump
-subunit phosphorylation, we incubated rat soleus muscle in
phosphorylation medium with 25 mM glucose. High glucose
exposure was associated with a 3-fold increase in
-subunit
phosphorylation (Fig. 2
). In contrast to insulin, the glucose-induced
phosphorylation was abolished in the presence of 1 µM
GF109203X, indicating that conventional and/or novel PKCs are involved
in the process.
Phosphoamino acid analysis of Na+,K+-ATPase
-subunit phosphorylated in rat soleus muscle
To identify the
Na+,K+-ATPase
-subunit
amino acids phosphorylated in response to insulin, PMA, or high glucose
concentration in rat skeletal muscle, a phosphoamino acid analysis of
phosphorylated
-subunit was performed. After stimulation by insulin,
PMA, or high glucose concentrations, the
Na+,K+-ATPase
-subunit
was primarily phosphorylated on serine residues (Fig. 3
). A small amount of
32P-phosphate was also detected on threonine
residues. The same phosphoamino acid pattern has been reported
previously after analysis of purified
Na+,K+-ATPase
phosphorylated by PKC in vitro (6, 7, 35). In
contrast, a radiolabeled phosphotyrosine was detected only in the
Na+,K+-ATPase
-subunit
immunoprecipitated from soleus muscle incubated with insulin.
|
-subunit isoforms in rat
soleus muscle
-subunit
indicates that
Na+,K+-ATPase in rat soleus
muscle is phosphorylated by a tyrosine kinase in response to insulin.
To determine whether insulin-stimulated
-subunit tyrosine
phosphorylation is time-dependent and isoform-specific, soleus muscles
were exposed to insulin (120 nM) for 330 min. Muscle
lysates were subjected to immunoprecipitation with antiphosphotyrosine
PY20 antibody, followed by immunoblot analysis with anti-NK1 antibody
raised against the
Na+,K+-ATPase holoenzyme
(Fig. 4B
1- and
2-isoforms of the
Na+,K+-ATPase
-subunit
(Fig. 4A
-subunit was
observed at 10 min after insulin exposure and decreased thereafter. The
maximal effect of insulin on 32P incorporation
into
-subunit (Fig. 1
|
1- and
2-isoforms of
Na+,K+-ATPase
(36). To assess whether insulin selectively increases
tyrosine phosphorylation of these isoforms, muscle lysates were
subjected to immunoprecipitation with antiphosphotyrosine PY20
antibody, followed by Western blot analysis with specific
anti-
1- (Fig. 4C
2-subunit (Fig. 4D
1-subunit isoform of
Na+,K+-ATPase was
significantly phosphorylated on tyrosine residues under basal
conditions. After 30 min of insulin exposure, the
1-subunit tyrosine phosphorylation level was
increased 57%. However, after 10 min of insulin exposure, tyrosine
phosphorylation of the
2-subunit increased
6-fold. After 30 min of incubation, insulin-stimulated
Na+,K+-ATPase
2- subunit tyrosine phosphorylation was
nearly restored to the basal level. Thus, both
1- and
2-subunit
isoforms of Na+,K+-ATPase
are phosphorylated on tyrosine residues in response to insulin in rat
soleus muscles. However, the magnitude of response and time course are
different for
1- and
2-subunit isoforms. The PKC inhibitor
GF109203X had no effect on insulin-stimulated tyrosine phosphorylation
of
1- and
2-subunit
isoforms (data not shown).
Effect of insulin, PMA, and high extracellular glucose on
Na+,K+-ATPase activity in rat soleus muscle
To assess whether insulin modified the intrinsic activity of the
total Na+,K+-ATPase
cellular pool,
Na+,K+-ATPase activity was
measured under Vmax conditions in homogenates of
soleus muscles previously incubated with insulin or PMA. To prevent
possible dephosphorylation, the serine/threonine protein phosphatase
inhibitor okadaic acid (1 µM) and the tyrosine
phosphatase inhibitor peroxyvanadate (1 µM) were added to
the homogenization medium. Okadaic acid and peroxyvanadate did not
alter basal Na+,K+-ATPase
activity (data not shown). Incubation with insulin did not
significantly modify
Na+,K+-ATPase activity
(Fig. 5A
). To investigate whether the
lack of insulin effect is attributable to superimposition of an
inhibitory effect of PKC-dependent phosphorylation and a stimulatory
effect of PKC-independent phosphorylation, we incubated rat soleus
muscles with the PKC inhibitor GF109203X and insulin. Preincubation
with GF109203X did not unmask any effect of insulin on
Na+,K+-ATPase activity. In
contrast, a 30-min incubation with PMA led to 32% inhibition of
Na+,K+-ATPase activity
(Fig. 5B
). To assess whether high extracellular glucose induces changes
in Na+,K+-ATPase activity,
we incubated rat soleus muscle in medium with 25 mM
glucose. High glucose exposure led to a 30% decrease in
Na+,K+-ATPase activity
(Fig. 5B
). The glucose-induced inhibition was abolished in the presence
of both 1 and 5 µM GF109203X, indicating that this
effect is PKC-dependent. The ouabain-insensitive ATPase activity
did not change in response to insulin, PMA, or high extracellular
glucose (data not shown).
|
-subunits
redistribution and Na+,K+-ATPase activity in
cell surface membranes from rat soleus muscle
2-subunit
translocation to the plasma membranes in skeletal muscle, after insulin
injection in animals, has been previously reported (23, 24). In our study, we incubated isolated rat soleus muscles
ex vivo with insulin and high extracellular glucose. This
setup allows us to exclude possible secondary effects of injection of
high concentrations of insulin in vivo. Cell surface
membrane fractions were isolated by differential centrifugations and
discontinuous sucrose gradients. Fig. 6A
2-subunit in cell surface membrane
fractions (Fig. 6
1-subunit (Fig. 6A
|
| Discussion |
|---|
|
|
|---|
-subunits
in rat skeletal muscle (Fig. 1
In contrast to results reported for kidney proximal convoluted
tubule cells (20), insulin-stimulated
Na+,K+-ATPase
-subunit
phosphorylation is partially PKC-dependent in rat soleus muscle.
Insulin not only stimulates tyrosine phosphorylation, but also
serine/threonine phosphorylation, of the
Na+,K+-ATPase
-subunit.
Preincubation with 5 µM GF109203X, a specific PKC
inhibitor, partially prevented the phosphorylation of the
Na+,K+-ATPase
-subunit.
Interestingly, 1 µM GF109203X did not inhibit
insulin-stimulated
Na+,K+-ATPase
-subunit
phosphorylation, suggesting that atypical, rather then
conventional/novel, PKC isoforms are likely involved. The insulin
receptor tyrosine kinase inhibitor
HNMPA-(AM)3 completely blocked the
insulin-mediated phosphorylation of the
Na+,K+-ATPase
-subunit.
These results indicate that PKC activation is downstream of insulin
receptor tyrosine kinase. Thus, insulin receptor stimulation may lead
to an activation and translocation to the membrane of atypical PKC
isoforms (38, 39), which may phosphorylate the
Na+,K+-ATPase
-subunits
on serine and threonine residues.
To further compare the insulin-stimulated
Na+,K+- ATPase
-subunit phosphorylation with the PKC-mediated phosphorylation, we
have used activators of PKC, specifically PMA, and high extracellular
glucose concentrations that may be physiologically important for
skeletal muscle. Indeed, both high extracellular glucose and insulin
activate PKCs in skeletal muscle (22, 34). High glucose
concentrations induce translocation of PKCß2 and (to a lesser extent)
PKC
, to the membrane in rat soleus muscle (34).
Hyperglycemia is known to reduce
Na+,K+-ATPase activity via
a PKC-dependent mechanism in vascular smooth muscle cells
(26) and in pancreatic ß-cells (27). Our
results from the phosphorylation experiments and the phosphoamino acid
analysis provide direct evidence of PKC-dependent Na-pump
phosphorylation in response to an increase in the extracellular glucose
concentration in skeletal muscle, a tissue which accounts for 80% of
total glucose disposal. In contrast to insulin-induced phosphorylation,
high glucose most likely activates different PKC isoforms in skeletal
muscle (in particular, conventional and novel), the activity of which
is regulated by [Ca2+]i
and diacylglycerol. The specific role of different PKC isoforms in
phosphorylation and regulation of skeletal muscle Na-pump warrants
further investigation.
Interestingly, we show threonine phosphorylation of
Na+,K+-ATPase
-subunit
in skeletal muscle in response to insulin. PKC-mediated phosphorylation
of Thr-15 has been described in a detailed site-directed mutagenesis
study of
1-subunit from Bufo
marinus, although Thr-15 accounted for only a small percentage of
total phosphorylation (40, 41). PKC-mediated
phosphorylation on threonine residues has also been described in
several other studies, including in vitro phosphorylation of
Na+,K+-ATPase preparations
from different species containing the
1-subunit (6, 7, 35) and intact
rat kidney proximal convoluted tubule cells (20).
Thr-15 is not present in rat
1-subunit,
although rat
2- has Thr at positions 14 and 15
(41). Furthermore, PKC can induce phosphorylation on only
threonine residues in a fusion protein containing the N-terminus of rat
2-subunit (41). The present work
demonstrates that threonine residues are phosphorylated under different
stimulation conditions in the
Na+,K+-ATPase
-subunit
in rat soleus muscle. Regardless of whether threonine residues are a
target for PKC or for another serine/threonine protein kinase, the
sites of phosphorylation and their physiological role(s) remain to
be determined.
Determination of the total phosphorylation level of the
Na+,K+-ATPase with
32P-labeling does not allow the detection of
isoform-specific phosphorylation, because the antibody used recognizes
both
1- and
2-subunit
isoforms (Fig. 4A
). Furthermore, a specific immunoprecipitating
anti-
2-subunit isoform antibody was not
available. However, immunoprecipitation with antiphosphotyrosine
antibody and subsequent Western blot analysis with
anti-
1- and -
2-
subunit antibodies revealed that both
1-
and
2-subunit isoforms underwent
phosphorylation on tyrosine residues in response to insulin in rat
soleus muscle, although with a different time course (Fig. 4
, CD).
Thus, phosphorylation of the
2-, but not the
1-, subunit isoform seems to account for the
observed insulin effect.
The molecular nature of the tyrosine kinase that phosphorylates
Na+,K+-ATPase in soleus
muscle is not yet identified. Although the insulin receptor tyrosine
kinase inhibitor HNMPA-(AM)3 completely blocked
insulin-mediated phosphorylation of the
Na+,K+-ATPase
-subunit,
involvement of nonreceptor tyrosine kinases cannot be excluded
(42). Moreover, recent studies reveal a functional
association between the insulin receptor and downstream effectors,
including phosphatidylinositol 3-kinase and nonreceptor tyrosine kinase
c-src (43). Our preliminary results indicate
that c-src phosphorylates the
-subunit of the
Na+,K+-ATPase in
vitro in skeletal muscle plasma membrane preparation (Chibalin,
A. V., M. V. Kovalenko, and J. R. Zierath, unpublished
results).
Although Tyr-10 is a target for tyrosine kinases in the rat
Na+,K+-ATPase
1-subunit isoform (20), the same
residue is not likely to undergo phosphorylation in
2-subunit isoform. Tyr-10 is conserved and
present in the rat
2-subunit sequence;
however, the environment of this residue is different. In the rat
1-subunit isoform, Tyr-10 is located in the
sequence DKYEP- and surrounded by negatively charged amino
acid residues at positions -2 and +1. This characterizes a consensus
phosphorylation site for nonreceptor tyrosine kinases
(44). In the rat
2-subunit
isoform, the tyrosine residue is located in the sequence REYSP-, and
it is surrounded by only one negatively charged residue at position
-1. Although we have not yet attempted to localize the tyrosine
phosphorylation site in the rat
2-subunit
sequence experimentally, sequence comparison with PhosphoBase database
(The Center for Biological Sequence Analysis, The Technical University
of Denmark, Lyngly, Denmark) (45, 46) predicts
Tyr-543 as a most probable target for tyrosine kinases in rat
Na+,K+-ATPase
2-subunit. This tyrosine residue is located in
the large cytoplasmic loop of
Na+,K+-ATPase
-subunit
(5), and it is surrounded by the sequence AYMELG-.
Interestingly, the sequence motif YMEL- is very similar to clathrin
adaptor protein 2-recognized tyrosine-based endocytic motif
(47), used for sorting proteins from the plasma membrane
to endosomes (48), including
1-subunit of rat
Na+,K+-ATPase
(49). An attractive hypothesis could be that
insulin-stimulated phosphorylation of Tyr-543 arrests the formation of
an endocytic complex of
Na+,K+-ATPase
2-subunit, adaptor protein 2, and clathrin.
This may prevent the
Na+,K+-ATPase
2-subunit from undergoing endocytosis from the
plasma membrane and may lead to an increased
2-subunit abundance in plasma membrane caused
by constitutive exocytosis. This hypothesis may offer a partial
explanation for the mechanism involved in insulin-stimulated
Na+,K+-ATPase
2-subunit translocation to the plasma membrane
in skeletal muscle. However, the involvement of PKC-dependent
phosphorylation in regulation of the
Na+,K+-ATPase intracellular
traffic cannot be excluded (13, 14). The transient time
course of
2-subunit phosphorylation would
prevent hyperactivity of the
Na+,K+-ATPase in a plasma
membrane that can lead to hyperpolarization of the membrane and
hypokalemea. This transient phosphorylation may be attributable to
protein phosphatase activity. Serine/threonine protein phosphatases are
involved in insulin regulation of
Na+,K+-ATPase activity in
cultured L6 rat skeletal muscle cells (50). However, the
involvement of specific phosphatases in the regulation of
Na+,K+-ATPase activity by
insulin in intact muscle is difficult to prove definitively without
detailed knowledge regarding the multiple phosphorylation sites on the
-subunit isoforms.
Stimulation of soleus muscle by insulin does not significantly change
total cellular
Na+,K+-ATPase catalytic
activity measured at Vmax in muscle homogenates.
Insulin has been reported to stimulate ouabain-suppressible
Rb+ uptake in isolated rat soleus muscle
(18) and
2-subunit translocation
to muscle surface membranes after insulin injection of animals
(23, 24). We have shown that ex vivo incubation
of isolated rat soleus muscle with insulin leads to
2-subunit translocation to cell surface
membranes, which correlates with an increase in total
Na+,K+-ATPase activity.
Importantly, the increase in
Na+,K+-ATPase activity can
be observed only in plasma membrane-enriched, but not in crude,
membrane fractions. The majority (7580%) of the
Na+,K+-ATPase pool in rat
soleus muscle corresponds to the
2-subunit
(51); therefore, comparison of
2-subunit abundance and
Na+,K+-ATPase activity in
cell surface membranes fractions suggests that the observed increase in
activity is a result of
Na+,K+-ATPase translocation
to the plasma membrane. Taken together, the data support the hypothesis
that insulin stimulation of
Na+,K+-ATPase in skeletal
muscle is attributable to an increase in the number of Na-pump units in
the plasma membrane, rather than a change in the activity of a single
pump unit. However, a possible change in Na+
affinity of the enzyme cannot be excluded.
In contrast to insulin, muscle exposure to PMA or high extracellular
glucose leads to decrease in
Na+,K+-ATPase activity
measured in homogenates. The inhibition of
Na+,K+-ATPase activity by
high glucose is PKC-dependent. Interestingly, the inhibitory effect is
maximal in homogenates and decreases throughout membrane purification.
This could be explained as a result of dephosphorylation of the
Na+,K+-ATPase during the
long process of membrane fractionation. Furthermore, proteins which can
bind to phosphorylated
Na+,K+-ATPase
-subunit
and may inhibit the ATPase activity of sodium pump units may be washed
away during series of centrifugations.
In conclusion, the present study demonstrates that insulin and high
extracellular glucose phosphorylate
Na+,K+-ATPase
-subunit in skeletal muscle at multiple sites. High extracellular
glucose promotes phosphorylation on only serine and threonine residues,
whereas insulin stimulates phosphorylation on both serine/threonine and
tyrosine residues. Although the phosphorylation state needs to be
directly linked with changes in Na-pump activity in skeletal muscle,
this mechanism is likely to play an important role maintaining the
intracellular distribution of
Na+,K+-ATPase units and the
regulation of Na+- and
K+-gradients.
| Acknowledgments |
|---|
1- and anti-
2-subunit antibodies. We especially thank Dr.
Arne Östman and Dr. Anna Krook for helpful discussions and
critical reading of the manuscript. We also thank Dr. Jorge
Rincón and Maria Fernström for their contributions to the
muscle incubation experiments. | Footnotes |
|---|
Abbreviations: ATPase, Adenosine triphosphatase; GLUT, glucose transporter; HNMPA-(AM)3, hydroxy-2-naphthalenylmethylphosphonic acid trisacetoxymethyl ester; KHB, Krebs Henseleit buffer; PMA, phorbol 12-myristate 13-acetate; Vmax, maximum velocity.
Received November 13, 2000.
Accepted for publication April 4, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. Green Reply to Fairchild J Appl Physiol, January 1, 2008; 104(1): 316 - 316. [Full Text] [PDF] |
||||
![]() |
H. J. Green, T. A. Duhamel, G. P. Holloway, J. W. Moule, J. Ouyang, D. Ranney, and A. R. Tupling Muscle Na+-K+-ATPase response during 16 h of heavy intermittent cycle exercise Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E523 - E530. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Schoner and G. Scheiner-Bobis Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Stewart, T. A. Duhamel, K. P. Foley, J. Ouyang, I. C. Smith, and H. J. Green Protection of muscle membrane excitability during prolonged cycle exercise with glucose supplementation J Appl Physiol, July 1, 2007; 103(1): 331 - 339. |